The proposed research will elucidate molecular mechanisms by which G proteins regulate effectors and are themselves regulated. Because G proteins are central to regulation of multiple cellular pathways, a clear understanding of their molecular function is ultimately critical for recognition of many disease processes and their treatment.
Aim 1 will define the dynamic components of G alpha-i1 that are coupled to GTP hydrolysis and conformational changes and that result in the termination of its signaling activity. Proline or Glycine mutations shall be introduced to constrain or relax backbone conformation at permissive sites throughout the molecule. Rates of nucleotide dissociation, conformational change and GTP hydrolysis shall be measured, and crystal structures determined of mutants with altered properties. Molecular dynamics calculations will be used to find correlations between changes in function and structure and alterations in essential dynamic components.
Aim 2 will address the mechanism by which p115Rho GEF is stimulated by G alpha-13, leading to the activation of the small G protein Rho, which induces stress fiber formation required for cell motility. The crystal structure of p115Rho GEF shall be determined, together with those of its complexes with G alpha-13/i chimeras and RhoA, singly and in combination. To accomplish this goal, well-expressed chimeric proteins containing structural elements of G alpha-i1 and G alpha-13 will be used, in their GDP-magnesium fluoroaluminate form, together with negative-dominant mutants of RhoA to stabilize the desired complexes.
The third aim explores a newly discovered G protein-coupled receptor independent pathway in which G alpha-i controls asymmetric cell division, and Ric-8 serves as the GEF for Galpha-i1. Complexes of G alpha-i1 with Ric-8, or subdomains of Ric-8 identified by sequence analysis and proteolytic mapping of Ric-8, shall be formed in the absence of nucleotide. These, together with Ric-8 alone will be crystallized and structures of Ric-8 and its complexes with G alpha-i1 determined. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
7R01DK046371-14
Application #
7271217
Study Section
Macromolecular Structure and Function C Study Section (MSFC)
Program Officer
Sechi, Salvatore
Project Start
1994-08-01
Project End
2009-05-31
Budget Start
2007-08-01
Budget End
2009-05-31
Support Year
14
Fiscal Year
2007
Total Cost
$244,069
Indirect Cost
Name
University of Montana
Department
Type
Organized Research Units
DUNS #
010379790
City
Missoula
State
MT
Country
United States
Zip Code
59812
Maziarz, Marcin; Leyme, Anthony; Marivin, Arthur et al. (2018) Atypical activation of the G protein G?q by the oncogenic mutation Q209P. J Biol Chem 293:19586-19599
Sprang, Stephen R (2016) Invited review: Activation of G proteins by GTP and the mechanism of G?-catalyzed GTP hydrolysis. Biopolymers 105:449-62
Chan, Puiyee; Thomas, Celestine J; Sprang, Stephen R et al. (2013) Molecular chaperoning function of Ric-8 is to fold nascent heterotrimeric G protein ? subunits. Proc Natl Acad Sci U S A 110:3794-9
Chen, Zhe; Guo, Liang; Hadas, Jana et al. (2012) Activation of p115-RhoGEF requires direct association of G?13 and the Dbl homology domain. J Biol Chem 287:25490-500
Seifert, Roland; Lushington, Gerald H; Mou, Tung-Chung et al. (2012) Inhibitors of membranous adenylyl cyclases. Trends Pharmacol Sci 33:64-78
Thomas, Celestine J; Briknarová, Klára; Hilmer, Jonathan K et al. (2011) The nucleotide exchange factor Ric-8A is a chaperone for the conformationally dynamic nucleotide-free state of G?i1. PLoS One 6:e23197
Erdorf, Miriam; Mou, Tung-Chung; Seifert, Roland (2011) Impact of divalent metal ions on regulation of adenylyl cyclase isoforms by forskolin analogs. Biochem Pharmacol 82:1673-81
Hübner, Melanie; Dixit, Anshuman; Mou, Tung-Chung et al. (2011) Structural basis for the high-affinity inhibition of mammalian membranous adenylyl cyclase by 2',3'-o-(N-methylanthraniloyl)-inosine 5'-triphosphate. Mol Pharmacol 80:87-96
Chen, Zhe; Medina, Frank; Liu, Mu-ya et al. (2010) Activated RhoA binds to the pleckstrin homology (PH) domain of PDZ-RhoGEF, a potential site for autoregulation. J Biol Chem 285:21070-81
Palmioli, Alessandro; Sacco, Elena; Abraham, Sherwin et al. (2009) First experimental identification of Ras-inhibitor binding interface using a water-soluble Ras ligand. Bioorg Med Chem Lett 19:4217-22

Showing the most recent 10 out of 47 publications